Recent Updates
Recently added Catalysts
KYMR Positive Sentiment Score: 60/100

Kymera Therapeutics to Report Third Quarter 2024 Financial Results on October 31

Wednesday, October 23, 2024 1 min read
Key Takeaway: Kymera Therapeutics, a clinical-stage biopharmaceutical company, will announce its third quarter 2024 financial results on October 31, 2024. The company specializes in targeted protein degradation and will host a conference call at 8:30 a.m. ET to discuss these results. Interested parties can participate via phone or a live webcast. A replay of the call will be available afterward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Kymera Therapeutics is set to report its financial results.
  • The company is advancing a promising new class of small molecule medicines.
  • A conference call will provide insight into the company's performance.

Full Press Release Details

WATERTOWN, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), will report third quarter 2024 financial results on October 31, 2024, and will host a conference call at 8:30 a.m. ET.
To access the October 31 conference call via phone, please dial +1 (833) 630-2127 (US) or +1 (412) 317-1846 (International) and ask to join the Kymera Therapeutics call. A live webcast of the Company’s conference call will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event.
About Kymera Therapeutics
Investor and Media Contact:
Vice President, Investor Relations
investors@kymeratx.com

Tags

Targeted Protein Degradation

Frequently Asked Questions

When will Kymera report its Q3 2024 financial results?

Kymera Therapeutics will report its third quarter 2024 financial results on October 31, 2024.

What time is the Kymera conference call?

The conference call is scheduled for 8:30 a.m. ET on October 31, 2024.

How can I access the conference call?

Access the call by dialing +1 (833) 630-2127 for US or +1 (412) 317-1846 for international.

Is there a webcast for the conference call?

Yes, a live webcast will be available under the 'News and Events' section on their website.

Who can I contact for investor inquiries?

For investor inquiries, contact the Vice President of Investor Relations via investors@kymeratx.com.

Tags: KYMR Viatris Investor Conferences Healthcare biopharmaceutical financial results targeted protein degradation conference call
Last updated: Oct 23, 2024